XML 23 R11.htm IDEA: XBRL DOCUMENT v3.25.1
Inventory
 3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Inventory Inventory
At March 31, 2025 and December 31, 2024, the Company’s inventory primarily related to ORLADEYO. Inventory also included peramivir, which is primarily manufactured for the Company’s partners.
The Company’s inventories consisted of the following (in thousands):
March 31, 2025December 31, 2024
Raw materials$8,742 $10,006 
Work-in-process17,426 16,152 
Finished goods7,887 7,765 
Total inventory34,055 33,923 
Reserves(2,085)(2,649)
Total inventory, net$31,970 $31,274